cobas HCYS, Homocysteine Enzymatic Assay, Material Number REF 06542921190, for use on cobas c 701/702, in vitro test for total L-homocysteine
Published November 27, 2024 · Recall initiated: October 17, 2024
Summary
FDA records medical device Class II recall Z-0489-2025, published November 27, 2024 and initiated October 17, 2024. Recalling firm: Roche Diagnostics Operations, Inc.; Status: Ongoing; Reported quantity: 458 units; Lot: UDI/DI 04015630929979, Lot Number 747029, exp. 30-SEPT-2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Abnormal calibration signals and control recovery issues on the Homocysteine Enzymatic (HCYS) Assay can produce erroneous patient results (positive or negative bias)
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Roche Diagnostics Operations, Inc.
- Distributor
- US: NJ, TX, NY, FL, IN, TX, OK, SC, IA,
- Lot
- UDI/DI 04015630929979, Lot Number 747029, exp. 30-SEPT-2024
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAEnChroma Safety Glasses with Rx Indoor Universal Lenses: Martinez Cx1 Indoor Rx, SKU: Cx.PC.IN.MTZ.BK.Rx;November 27, 2024
- FDAa) Alcon Custom-Pak CONSTELLATION 25G PLUS CHRISTIANA CARE HLTH SERV, # 15340-11, containing TUBING, SALEMNovember 27, 2024
- FDACreatine Kinase (CK) used on cobas c 311/501/502 and COBAS INTEGRA 400 plus-In vitro test for the quantitativeOctober 2, 2024
- FDAAlbumin Gen.2, Catalog 05166861190October 21, 2020
- FDAElecsys Anti-HAV IgM assay-for the in vitro qualitative detection of IgM antibodies to hepatitis A virusDecember 18, 2019
- FDAOnline TDM Vancomycin Gen.3 (100 tests) Catalog # 06779336190 Analyzer/Module: cobas c 311 and cobas c 501/502October 16, 2019
Questions about this recall
Was cobas HCYS, Homocysteine Enzymatic Assay, Material Number REF 06542921190, for use on cobas c 701/702, in vitro test for total L-homocysteine recalled?
Yes. FDA published recall Z-0489-2025 on November 27, 2024. Reported hazard: Abnormal calibration signals and control recovery issues on the Homocysteine Enzymatic (HCYS) Assay can produce erroneous patient results (positive or negative bias)
What should I do if I have this product?
Voluntary: Firm initiated · Letter